06:48 AM EDT, 05/05/2025 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) reported a Q1 net loss Monday of $0.50 per diluted share, widening from a loss of $0.39 a year earlier.

Analysts polled by FactSet expected a loss of $0.39.

Revenue for the quarter ended March 31 was $14.7 million, up from $13.7 million a year earlier.

Analysts surveyed by FactSet expected $15 million.

Recursion shares were down 4.5% in recent premarket activity.